C4 Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Hello, everyone. I'm Nader Sohraby from the JPMorgan Healthcare Investment Banking team. On behalf of JPMorgan, it's my pleasure to introduce Andrew Hirsch, the President and CEO of C4 Therapeutics.
As a reminder, we'll try to reserve a few minutes at the end for Q&A. So if you have any questions, please submit them online using the ask-a-question feature at the bottom of the screen.
Thank you, and I'll now turn it over to Andrew.
Thank you, Nader, for the introduction. Good afternoon, and thank you for joining our presentation today.
Before I begin, I'd like to thank JPMorgan for inviting us to participate in the conference. I'm really pleased to provide an update on C4 Therapeutics today. I'm sure that most of you know the drill by now, but you should all have access to the slides. Iâll indicate which slide number I'm on as I move through the presentation. After the presentation, Stew Fisher, our CSO; Adam
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |